Connection

PETER LIN to Anticoagulants

This is a "connection" page, showing publications PETER LIN has written about Anticoagulants.
Connection Strength

2.084
  1. Sustained Thromboresistant Bioactivity with Reduced Intimal Hyperplasia of Heparin-Bonded Polytetrafluoroethylene Propaten Graft in a Chronic Canine Femoral Artery Bypass Model. Ann Vasc Surg. 2018 May; 49:295-303.
    View in: PubMed
    Score: 0.418
  2. Comparison of propaten heparin-bonded vascular graft with distal anastomotic patch versus autogenous saphenous vein graft in tibial artery bypass. Vascular. 2018 Apr; 26(2):117-125.
    View in: PubMed
    Score: 0.410
  3. Prognostic factors and treatment outcome in mesenteric vein thrombosis. Vasc Endovascular Surg. 2008 Jun-Jul; 42(3):217-24.
    View in: PubMed
    Score: 0.213
  4. Low molecular weight heparin induced priapism. J Urol. 2004 Jul; 172(1):263.
    View in: PubMed
    Score: 0.165
  5. Evaluation of platelet deposition and neointimal hyperplasia of heparin-coated small-caliber ePTFE grafts in a canine femoral artery bypass model. J Surg Res. 2004 May 01; 118(1):45-52.
    View in: PubMed
    Score: 0.163
  6. Carotid stenting using heparin-coated balloon-expandable stent reduces intimal hyperplasia in a baboon model. J Surg Res. 2003 Jun 01; 112(1):84-90.
    View in: PubMed
    Score: 0.153
  7. Association Between Patient and Physician Sex and Physician-Estimated Stroke and Bleeding Risks in Atrial Fibrillation. Can J Cardiol. 2019 02; 35(2):160-168.
    View in: PubMed
    Score: 0.112
  8. The Risk Stratification and Stroke Prevention Therapy Care Gap in Canadian Atrial Fibrillation Patients. Can J Cardiol. 2016 Mar; 32(3):336-43.
    View in: PubMed
    Score: 0.090
  9. Risk stratification and stroke prevention therapy care gaps in Canadian atrial fibrillation patients (from the Co-ordinated National Network to Engage Physicians in the Care and Treatment of Patients With Atrial Fibrillation chart audit). Am J Cardiol. 2015 Mar 01; 115(5):641-6.
    View in: PubMed
    Score: 0.085
  10. Primary prophylaxis of venous thromboembolism in surgical patients. Vasc Endovascular Surg. 2008 Jun-Jul; 42(3):205-16.
    View in: PubMed
    Score: 0.053
  11. Percutaneous stenting of superior vena cava syndrome: treatment outcome in patients with benign and malignant etiology. Vascular. 2007 Sep-Oct; 15(5):314-21.
    View in: PubMed
    Score: 0.051
  12. The case for thrombolysis for iliofemoral venous thrombosis. Semin Vasc Surg. 2005 Sep; 18(3):139-47.
    View in: PubMed
    Score: 0.045
  13. What is the learning curve for carotid artery stenting with neuroprotection? Analysis of 200 consecutive cases at an academic institution. Perspect Vasc Surg Endovasc Ther. 2005 Jun; 17(2):113-23.
    View in: PubMed
    Score: 0.044
  14. Transient ischemic attack due to early carotid stent thrombosis: successful rescue with rheolytic thrombectomy and systemic abciximab. J Endovasc Ther. 2003 Oct; 10(5):870-4.
    View in: PubMed
    Score: 0.039
  15. Catheter-directed thrombolysis for severe pulmonary embolism in pediatric patients. Ann Vasc Surg. 2014 Oct; 28(7):1794.e1-7.
    View in: PubMed
    Score: 0.020
  16. Radiation-associated venous stenosis: endovascular treatment options. J Vasc Surg. 2004 Jul; 40(1):179-82.
    View in: PubMed
    Score: 0.010
  17. Spontaneous arterial thrombosis in a patient with human immunodeficiency virus infection: successful treatment with pharmacomechanical thrombectomy. J Vasc Surg. 2003 Aug; 38(2):392-5.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.